DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr | ₹41 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-1,045 Cr |
Mar2022 | ₹-816 Cr |
Mar2021 | ₹1,987 Cr |
Mar2020 | ₹41 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-1,045 Cr | Negative | |
Mar2022 | ₹-816 Cr | Negative | |
Mar2021 | ₹1,987 Cr | 4,740.85 | |
Mar2020 | ₹41 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹178,489.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,512.2 Cr | 1.4% | -6.4% | 11.8% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 2.6% |
8.4% |
48.5% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses